Mindoo

Based in Belgium, Mindoo provides AI systems that enhance operational efficiency within healthcare teams, focusing on automating routine administrative tasks to enable better patient care. Mindoo specializes in AI-driven solutions for healthcare, enhancing workflow efficiency. Founded in 2025 in Brussels, Belgium, the company has completed one deal to date. The most recent funding was a Seed round on December 16, 2025, raising EUR 5 million from 6 Degrees Capital and Syndicate One.

Mindoo offers an innovative suite of AI-driven solutions designed to enhance efficiency within healthcare teams. The core product focuses on automating routine tasks such as patient intake, call handling, symptom logging, and follow-up coordination, allowing healthcare professionals to concentrate on patient care. By utilizing AI agents like Max, the intake agent, and various customizable solutions, Mindoo streamlines the workflow from the moment a patient schedules an appointment until post-visit follow-ups. These products are tailored for healthcare facilities, including hospitals and clinics, and operate across multiple geographical markets, notably in North America and Europe.

Mindoo's services are particularly beneficial for clinicians who require assistance in managing increased patient demands amid tighter operational budgets and staffing constraints. Mindoo's revenue model is based on subscription agreements where healthcare providers integrate AI agents into their workflow. Clients typically subscribe to customized packages that suit their specific operational needs, allowing them to scale services as required. The transaction structure involves direct partnerships with healthcare entities, enhancing their administrative capabilities without increasing headcount.

Each subscription plan may include access to various AI agents that help with different aspects of patient management, ensuring that healthcare teams remain focused on patient care rather than administrative tasks. The company’s offerings are structured to create significant value for healthcare providers, enabling them to operate more efficiently in a challenging environment. In December 2025, Mindoo raised EUR 5 million in Seed funding to advance its healthcare AI workflow platform, complete the development of core AI agents, and expand its engineering, clinical, and deployment teams. The company aims to launch new product features and expand into additional North American and European markets by the end of 2026.